Can Postbiotics Help with Spring Allergic Rhinitis?

❮❯

1/6

Seasonal allergic rhinitis (SAR) is a condition in which the immune system mounts an IgE-mediated, type I hypersensitive response to airborne allergens such as spring pollen and poplar fluff, causing chronic inflammation of the nasal lining. Allergic rhinitis is estimated to affect 10%-40% of the global population, making it one of the most common chronic respiratory allergic conditions^[1]. In recent years, the ability of postbiotics to modulate immunity via the gut-airway axis has attracted growing scientific attention^[2].

What Are Postbiotics?

Postbiotics are the third generation of gut-active preparations formally defined in 2021 by the International Scientific Association for Probiotics and Prebiotics (ISAPP). The official definition: "a preparation of inanimate microorganisms and/or their components that confers a health benefit on the host"^[3].

The core difference from probiotics: probiotics must stay alive to work, whereas postbiotics consist of inactivated microorganisms and their metabolites and can modulate immune function without relying on live bacteria. That translates into a longer shelf life, more stable dosing, and a higher safety profile for people with weakened immune systems^[7].

How Postbiotics Support Allergic Rhinitis Relief: The Gut-Airway Axis

Mechanism 1: Rebalancing Th1/Th2 immunity

The core immune imbalance in allergic rhinitis is an overactive Th2 response paired with relatively subdued Th1 activity. Short-chain fatty acids and other postbiotic metabolites act on CD4⁺ T-cell differentiation: by promoting the proliferation of regulatory T cells (Tregs/Foxp3⁺) and lowering Th2 cytokines (IL-4, IL-13), they help address allergic inflammation at its source^[2].

Butyrate suppresses the transcription of the pro-inflammatory cytokines TNF-α and IL-6 by inhibiting histone deacetylase (HDAC) activity and enhancing Foxp3 promoter activity, thereby stabilizing Treg function^[6]. Clinical evidence shows that lower butyrate levels in people with allergic rhinitis are significantly associated with reduced Treg frequency and decreased Foxp3 expression.

Mechanism 2: Supporting the gut and nasal mucosal barriers

Postbiotic components — including secreted proteins, exopolysaccharides and short-chain fatty acids — help strengthen the integrity of tight junctions between intestinal epithelial cells, reducing the leakage of allergens and pro-inflammatory factors. This barrier-supporting effect appears to extend to the nasal mucosa as well^[4].

Mechanism 3: Inhibiting mast-cell degranulation

A 2025 study published in the Journal of Agricultural and Food Chemistry examined a postbiotic lysate derived from Bifidobacterium animalis subsp. lactis Bla36. In vitro, it inhibited mast-cell degranulation (reducing histamine and β-hexosaminidase release), lowered Th2 cytokines (IL-4, IL-6, TNF-α) and raised the anti-inflammatory cytokine IL-10. In an ovalbumin-induced mouse model of allergic rhinitis, oral administration was associated with a 65.60%-77.74% drop in serum IgE, markedly relieved nasal inflammation, and no toxicity signals^[5].

Mechanism 4: Systemic regulation via the gut-airway axis

The "gut-airway axis" is an important recent finding in immunology: the gut microbiota and airway immunity engage in continuous, two-way signaling^[2]. Postbiotic metabolites originating in the gut can reach the airway mucosa through the bloodstream, influencing the local immune-cell landscape and inflammatory tone. In animal models, restoring butyrate-producing bacteria was associated with a significant drop in serum IgE and roughly 60% less nasal IL-13 secretion.

Limitations of the Current Evidence

1. Gap between animal models and human evidence: Most research on postbiotics for allergic rhinitis is still at the in-vitro or animal-model stage; more high-quality randomized, double-blind, controlled clinical trials are needed to confirm the findings^[8].
2. Strong strain specificity: Postbiotics derived from different strains vary considerably in function, so results cannot be generalized to every product. When choosing a product, look for specific strain designations and supporting clinical data.
3. Not a replacement for medical care: Postbiotics are currently an adjunctive approach and cannot replace mainstream clinical options such as nasal corticosteroids, antihistamines or allergen immunotherapy^[1].
4. Baseline gut health matters: Because postbiotics work through the gut-airway axis, the baseline diversity and health of the gut microbiota can influence their effect.

Practical Management Tips for Spring Allergic Rhinitis

Beyond considering postbiotic supplements, the following everyday measures are also supported by evidence:

• Allergen avoidance: Limit outdoor activity during peak pollen hours (10 a.m. to 3 p.m. on sunny days), wear a mask when outside, and wash your hands and face promptly after returning home.
• Nasal rinsing: Rinsing with saline mechanically clears allergens from the nasal cavity and reduces local irritation.
• Prebiotic dietary support: Increase dietary fiber (legumes, whole grains, vegetables) to feed butyrate-producing gut bacteria, indirectly supporting the body's own production of postbiotic metabolites.
• Maintain gut health: Avoid unnecessary antibiotics — a cornerstone of preserving gut-microbiota diversity and keeping the gut-airway axis working as it should.